FDA.reportPublic FDA data

dapagliflozin

RxCUI
1488564
RxNorm name
dapagliflozin
Term type
IN
Status
Active
Updated
2026-08-12 12:31:09

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
032014
Active start
032014
Multiple ingredient
NO
Branded
NO

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRdapagliflozin1NAMES
RxNorm Namedapagliflozin1NAMES
TTYIN1ATTRIBUTES
SPL_SET_ID
38 linked values
38CODES
UNII_CODE1ULL0QJ8UC1CODES
RxCUI14885641CODES
MMSL_CODE
3 linked values
3CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 27 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
DapagliflozinDAPAGLIFLOZINAurobindo Pharma Limitedf56593f7-588e-489d-9fad-b459e90dab182026-07-17Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
FARXIGADAPAGLIFLOZINA-S Medication Solutions01f90c94-71cb-4a1f-81ff-8004b850529b2026-07-10Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
dapagliflozinDAPAGLIFLOZINMacleods Pharmaceuticals Limited91373924-66dc-4277-aaf2-8536e81a0e4d2026-07-09Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DAPAGLIFLOZINDAPAGLIFLOZINFlorida Pharmaceutical Products, LLC20a83ea2-6ad8-4bbb-b516-73c0a9e373992026-07-02Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINANI Pharmaceuticals, Inc.6425d240-5dd9-4a2c-9348-f8a8597028502026-06-29Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINAscend Laboratories, LLCb6b8a10c-64c3-4856-8961-d72d68784f5d2026-06-25Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DAPAGLIFLOZINDAPAGLIFLOZINAlembic Pharmaceuticals Inc.840e2146-2383-489b-bcc4-fecfe986685a2026-06-23Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINZydus Pharmaceuticals USA Inc.17586ec6-0104-4b08-ad87-12a837568d6c2026-06-22Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINNovadoz Pharmaceuticals LLC107b4d25-4764-42b7-80e3-9aaff20865ed2026-06-17Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
FARXIGADAPAGLIFLOZINAstraZeneca Pharmaceuticals LP72ad22ae-efe6-4cd6-a302-98aaee423d692026-06-03Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DAPAGLIFLOZINDAPAGLIFLOZINPrasco Laboratories3aba33aa-f8c6-4b10-85c8-dfa14578d07c2026-06-03Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINAvKARE52a778e7-6044-2049-e063-6294a90aa0b72026-05-27Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINA-S Medication Solutionsaddc6ead-f9e3-4b40-aed1-bc008a5c9b0f2026-05-18Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINA-S Medication Solutionsc4264ff6-5199-49e9-91d3-3ad67b42f88d2026-05-18Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
FARXIGADAPAGLIFLOZINREMEDYREPACK INC.ef9e9c8c-5460-4193-952a-0c249dd071bd2026-04-24Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DAPAGLIFLOZINDAPAGLIFLOZINAlembic Pharmaceuticals Limitedd44f7eed-dd51-40d1-8408-8fb331e1f1f62026-04-21Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINApotex Corp.bd9766c5-104f-4636-897d-b6c92eb94f182026-04-10Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DAPAGLIFLOZINDAPAGLIFLOZINCipla USA Inc.a2f86c0a-ce78-4d06-b5d8-ed457c8e36142026-04-08Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINZydus Lifesciences Limiteddb668c5c-2d49-41c8-8ffd-c2b2652b621a2026-04-06Name fallback
generic name: DAPAGLIFLOZIN
DapagliflozinDAPAGLIFLOZINLupin Pharmaceuticals, Inc.08baca21-e39e-4e61-961f-d89432fe80072026-04-02Warnings, Adverse reactionsName fallback
generic name: DAPAGLIFLOZIN

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA10BDCombinations of oral blood glucose lowering drugsATC1-4dapagliflozin / metformin
ATCA10BDCombinations of oral blood glucose lowering drugsATC1-4dapagliflozin / metformin / saxagliptin
ATCA10BDCombinations of oral blood glucose lowering drugsATC1-4dapagliflozin / saxagliptin
ATCA10BKSodium-glucose co-transporter 2 (SGLT2) inhibitorsATC1-4dapagliflozin
FDASPLN0000187059Sodium-Glucose Cotransporter 2 InhibitorEPChas_epcdapagliflozin
FDASPLN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTD001559Benzhydryl CompoundsCHEMhas_ingredientdapagliflozin
MEDRTD005960GlucosidesCHEMhas_ingredientdapagliflozin
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatdapagliflozin propanediol
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatdapagliflozin 2,3-butanediol monohydrate
MEDRTD003924Diabetes Mellitus, Type 2DISEASEmay_treatdapagliflozin
MEDRTD004342Drug HypersensitivityDISEASEci_withdapagliflozin propanediol
MEDRTD006333Heart FailureDISEASEmay_treatdapagliflozin 2,3-butanediol monohydrate
MEDRTD006333Heart FailureDISEASEmay_treatdapagliflozin
MEDRTD051437Renal InsufficiencyDISEASEci_withdapagliflozin propanediol
MEDRTN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin 2,3-butanediol monohydrate
MEDRTN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin
MEDRTN0000187058Sodium-Glucose Transporter 2 InhibitorsMOAhas_moadapagliflozin propanediol
MEDRTN0000175650Decreased Sympathetic ActivityPEhas_pedapagliflozin
MEDRTN0000175650Decreased Sympathetic ActivityPEhas_pedapagliflozin 2,3-butanediol monohydrate
MEDRTN0000009556Increased Renal Organic Ion ExcretionPEhas_pedapagliflozin
MEDRTN0000009556Increased Renal Organic Ion ExcretionPEhas_pedapagliflozin 2,3-butanediol monohydrate
MEDRTN0000009556Increased Renal Organic Ion ExcretionPEhas_pedapagliflozin propanediol
MEDRTN0000009830Renal Ion Transport AlterationPEhas_pedapagliflozin
MEDRTN0000009830Renal Ion Transport AlterationPEhas_pedapagliflozin propanediol
MEDRTN0000009830Renal Ion Transport AlterationPEhas_pedapagliflozin 2,3-butanediol monohydrate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESRXNAV_HUMAN_DRUGUS
CODESATCA10BK01
CODESDRUGBANKDB06292
CODESSNOMEDCT703674001
CODESSNOMEDCT703678003
CODESUSPm17996
CODESVUID4033035
SOURCESSourceAnatomical Therapeutic Chemical
SOURCESSourceDrug Bank
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUnited States Pharmacopeia
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File